Sequent forays into Brazils pet market with acquisition of Nourrie

9 Mar 2022 , 01:33 AM

Sequent Scientific announced that Alivira Sade Animal Brazil a wholly owned subsidiary of the company has completed the acquisition of 100Percentage stake in Nourrie Sade e Nutrio Animal Nourrie With this acquisition Nourrie has become a wholly owned subsidiary of Alivira Sade Animal and consequently of the company The acquisition was made for a consideration of BRL 27 million USD 5 million SeQuent had originally announced signing of the binding agreement to acquire Nourrie on 16 December 2021 The conclusion of Nourries acquisition marks an important milestone in Sequent 20 strategy of establishing presence in Brazils pet market the fastest growing segment Brazil has the 4th largest pet market in the world with an estimated market size of BRL 18 Billion growing annually at ~16Percentage The addition of Nourries business has nearly doubled the product portfolio available to Alivira for commercialization in Brazil with additions in both the nutraceutical and therapeutic product categories Nourrie also brings a strong pipeline of 20 products under development 12 of which are planned for launch in the next fiscal